Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
Baker Bros. Advisors LP | 0 0.000% |
-1,995,200 (Position Closed) |
Filing History |
| 2024-02-14 2:51 pm Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
Armistice Capital, LLC | 500,000 0.710% |
-2,988,000 (-85.67%) |
Filing History |
| 2024-02-14 09:13 am Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
AVORO CAPITAL ADVISORS LLC | 4,886,840 7.000% |
-668,715 (-12.04%) |
Filing History |
| 2024-02-14 07:12 am Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
RTW Investments, LP | 0 0.000% |
-3,643,114 (Position Closed) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Mirati Therapeutics, Inc. MRTX |
The Vanguard Group | 5,306,693 7.570% |
332,805 (+6.69%) |
Filing History |
| 2024-02-09 12:29 pm Sale |
2024-01-31 | 13G | Mirati Therapeutics, Inc. MRTX |
MORGAN STANLEY MS |
0 0.000% |
-6,079,302 (Position Closed) |
Filing History |
| 2024-02-09 12:20 pm Purchase |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
MORGAN STANLEY MS |
6,079,302 8.700% |
6,079,302 (New Position) |
Filing History |
| 2024-02-08 10:14 am Sale |
2023-12-29 | 13G | Mirati Therapeutics, Inc. MRTX |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-3,016,335 (Position Closed) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
BLACKROCK INC BLK |
3,866,202 5.500% |
1,109,527 (+40.25%) |
Filing History |
| 2024-01-25 4:31 pm Sale |
2024-01-23 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 0 0.000% |
-11,661,726 (Position Closed) |
Filing History |
| 2023-12-27 4:05 pm Purchase |
2023-12-18 | 13G | Mirati Therapeutics, Inc. MRTX |
EcoR1 Capital LLC | 7,396,979 10.500% |
1,648,580 (+28.68%) |
Filing History |
| 2023-10-12 1:07 pm Unchanged |
2023-10-08 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 11,661,726 15.900% |
0 (Unchanged) |
Filing History |
| 2023-10-02 4:08 pm Purchase |
2023-09-22 | 13G | Mirati Therapeutics, Inc. MRTX |
EcoR1 Capital LLC | 5,748,399 8.500% |
5,748,399 (New Position) |
Filing History |
| 2023-08-16 4:28 pm Purchase |
2023-08-11 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 11,661,726 15.900% |
1,370,879 (+13.32%) |
Filing History |
| 2023-02-14 2:35 pm Sale |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
PERCEPTIVE ADVISORS LLC | 2,191,425 3.800% |
-1,092,358 (-33.27%) |
Filing History |
| 2023-02-14 1:10 pm Purchase |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
Armistice Capital, LLC | 3,488,000 6.060% |
3,488,000 (New Position) |
Filing History |
| 2023-02-14 10:09 am Purchase |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
RTW Investments, LP | 3,643,114 6.300% |
3,643,114 (New Position) |
Filing History |
| 2023-02-14 09:34 am Purchase |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
AVORO CAPITAL ADVISORS LLC | 5,555,555 9.600% |
480,555 (+9.47%) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Mirati Therapeutics, Inc. MRTX |
The Vanguard Group | 4,973,888 8.640% |
534,911 (+12.05%) |
Filing History |
| 2023-02-06 2:53 pm Sale |
2022-12-30 | 13G | Mirati Therapeutics, Inc. MRTX |
WELLINGTON MANAGEMENT CO LLP | 3,016,335 5.240% |
-129,297 (-4.11%) |
Filing History |